Gelesis Joins OAC Chairman’s Council at Patron Level
This month, OAC is excited to welcome a new member to the OAC Chairman’s Council: Gelesis. Please join us in welcoming Gelesis for their support!
Gelesis has signed on to support OAC at the Patron Level of the Chairman’s Council and has partnered with OAC in our mission to elevate and empower individuals affected by obesity through awareness, education, advocacy and support.
Gelesis is a biotechnology company developing a novel category of therapies for GI-related chronic diseases. They recognize that a host of modern chronic diseases, such as obesity, non-alcoholic fatty liver disease, irritable bowel syndrome and diabetes, originate in the GI pathway. As such, the Gelesis portfolio includes a product for obesity and overweight as well as medications in the pipeline for other chronic diseases.
OAC Chairman’s Council
OAC is honored to have the Patron Level support of Gelesis and we continue to welcome any individual, organization or company who wishes to join our highest level of OAC Community Membership! The OAC Chairman’s Council is a powerful way to give back to our cause and play an integral role in helping OAC continue our initiatives and serve individuals affected by obesity year-round. We offer various levels of giving within the Chairman’s Council which showcase the generous and diverse support of our partnering individuals and organizations.
To learn more about the OAC Chairman’s Council or to join today, please CLICK HERE.